{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:48:13Z","timestamp":1740138493266,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005117","name":"Birjand University of Medical Sciences","doi-asserted-by":"publisher","award":["6317"],"award-info":[{"award-number":["6317"]}],"id":[{"id":"10.13039\/501100005117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12017-023-08757-y","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T15:02:11Z","timestamp":1694185331000},"page":"563-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a Novel ARSA Gene Mutation Through High-Throughput Molecular Diagnosis Method in Two Girls with Late Infantile Metachromatic Leukodystrophy"],"prefix":"10.1007","volume":"25","author":[{"given":"Abolfazl","family":"Yari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzane","family":"Vafaeie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra Miri","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahya","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Hashemzade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Sadat","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Ehsanbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Miri-Moghaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"issue":"1","key":"8757_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/CRISPR.2021.0075","volume":"5","author":"JS Antony","year":"2022","unstructured":"Antony, J. S., Daniel-Moreno, A., Lamsfus-Calle, A., Raju, J., Kaftancioglu, M., Ure\u00f1a-Bail\u00e9n, G., Rottenberger, J., Hou, Y., Santhanakumaran, V., Lee, J. H., & Heumos, L. (2022). A mutation-agnostic hematopoietic stem cell gene therapy for metachromatic leukodystrophy. The CRISPR Journal, 5(1), 66\u201379. https:\/\/doi.org\/10.1089\/CRISPR.2021.0075","journal-title":"The CRISPR Journal"},{"issue":"2","key":"8757_CR2","doi-asserted-by":"publisher","first-page":"e0282304","DOI":"10.1371\/JOURNAL.PONE.0282304","volume":"18","author":"Z Ataei","year":"2023","unstructured":"Ataei, Z., Nouri, Z., Tavakoli, F., Pourreza, M. R., Narrei, S., & Tabatabaiefar, M. A. (2023). Novel in-frame duplication variant characterization in late infantile metachromatic leukodystrophy using whole-exome sequencing and molecular dynamics simulation. PLoS ONE, 18(2), e0282304. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0282304","journal-title":"PLoS ONE"},{"key":"8757_CR3","volume-title":"Metachromatic leukodystrophy clinical","author":"I Barboura","year":"2012","unstructured":"Barboura, I., Maire, I., Ferchichi, S., Miled, A., Barboura, I., & Maire, I. (2012). Metachromatic leukodystrophy clinical. In Tan, U. (Ed.), Latest findings in intellectual and developmental disabilities research biological and therapeutic aspects. IntechOpen."},{"issue":"4","key":"8757_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/S10048-020-00621-6\/TABLES\/1","volume":"21","author":"S Beerepoot","year":"2020","unstructured":"Beerepoot, S., van Dooren, S. J. M., Salomons, G. S., Boelens, J. J., Jacobs, E. H., van der Knaap, M. S., van Kuilenburg, A. B., & Wolf, N. I. (2020). Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients. Neurogenetics, 21(4), 289\u2013299. https:\/\/doi.org\/10.1007\/S10048-020-00621-6\/TABLES\/1","journal-title":"Neurogenetics"},{"issue":"10","key":"8757_CR5","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1590\/1806-9282.66.10.1344","volume":"66","author":"FM Borges","year":"2020","unstructured":"Borges, F. M., Costa, M. J. G. D., Carneiro, Z. A., & Louren\u00e7o, C. M. (2020). Metachromatic leukodystrophy: Pediatric presentation and the challenges of early diagnosis. Revista Da Associacao Medica Brasileira, 66(10), 1461. https:\/\/doi.org\/10.1590\/1806-9282.66.10.1344","journal-title":"Revista Da Associacao Medica Brasileira"},{"issue":"5","key":"8757_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/S10545-011-9436-Z\/TABLES\/3","volume":"35","author":"R Giugliani","year":"2012","unstructured":"Giugliani, R. (2012). Newborn screening for lysosomal diseases: Current status and potential interface with population medical genetics in Latin America. Journal of Inherited Metabolic Disease, 35(5), 871\u2013877. https:\/\/doi.org\/10.1007\/S10545-011-9436-Z\/TABLES\/3","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"52","key":"8757_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/JNNP.S1-13.52.289","volume":"13","author":"JG Greenfield","year":"1933","unstructured":"Greenfield, J. G. (1933). A form of progressive cerebral sclerosis in infants associated with primary degeneration of the interfascicular glia. The Journal of Neurology and Psychopathology, 13(52), 289\u2013302. https:\/\/doi.org\/10.1136\/JNNP.S1-13.52.289","journal-title":"The Journal of Neurology and Psychopathology"},{"issue":"3","key":"8757_CR8","first-page":"57","volume":"9","author":"S Jabbehdari","year":"2015","unstructured":"Jabbehdari, S., Rahimian, E., Jafari, N., Sanii, S., Khayatzadehkakhki, S., & Nejad Biglari, H. (2015). The clinical features and diagnosis of Metachromatic leukodystrophy: A case series of Iranian Pediatric Patients. Iranian Journal of Child Neurology, 9(3), 57.","journal-title":"Iranian Journal of Child Neurology"},{"issue":"9","key":"8757_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/J.1469-8749.2011.04028.X","volume":"53","author":"C Kehrer","year":"2011","unstructured":"Kehrer, C., Blumenstock, G., Gieselmann, V., & Kr\u00e4geloh-Mann, I. (2011). The natural course of gross motor deterioration in metachromatic leukodystrophy. Developmental Medicine & Child Neurology, 53(9), 850\u2013855. https:\/\/doi.org\/10.1111\/J.1469-8749.2011.04028.X","journal-title":"Developmental Medicine & Child Neurology"},{"key":"8757_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/B978-0-444-59565-2.00029-0","volume":"113","author":"A Kohlsch\u00fctter","year":"2013","unstructured":"Kohlsch\u00fctter, A. (2013). Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophy. Handbook of Clinical Neurology, 113, 1611\u20131618. https:\/\/doi.org\/10.1016\/B978-0-444-59565-2.00029-0","journal-title":"Handbook of Clinical Neurology"},{"issue":"4","key":"8757_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/JMD2.12293","volume":"63","author":"L Laugwitz","year":"2022","unstructured":"Laugwitz, L., Santhanakumaran, V., Spieker, M., Boehringer, J., Bender, B., Gieselmann, V., Beck\u2010Woedl, S., Bruchelt, G., Harzer, K., Kraegeloh\u2010Mann, I., & Groeschel, S. (2022). Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long-term follow-up and review of the literature. JIMD Reports, 63(4), 292\u2013302. https:\/\/doi.org\/10.1002\/JMD2.12293","journal-title":"JIMD Reports"},{"issue":"5","key":"8757_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/JNNP-2018-319481","volume":"90","author":"DS Lynch","year":"2019","unstructured":"Lynch, D. S., Wade, C., De Paiva, A. R. B., John, N., Kinsella, J. A., Merwick, \u00c1., Ahmed, R. M., Warren, J. D., Mummery, C. J., Schott, J. M., & Fox, N. C. (2019). Practical approach to the diagnosis of adult-onset leukodystrophies: An updated guide in the genomic era. Journal of Neurology, Neurosurgery & Psychiatry, 90(5), 543\u2013555. https:\/\/doi.org\/10.1136\/JNNP-2018-319481","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"8757_CR13","doi-asserted-by":"publisher","first-page":"106448","DOI":"10.1016\/J.CLINEURO.2020.106448","volume":"201","author":"N Mahdieh","year":"2021","unstructured":"Mahdieh, N., Sharifi, A., Rabbani, A., Ashrafi, M., Tavasoli, A. R., Badv, R. S., Bonkowsky, J. L., & Rabbani, B. (2021). Novel disease-causing variants in a cohort of Iranian patients with metachromatic leukodystrophy and in silico analysis of their pathogenicity. Clinical Neurology and Neurosurgery, 201, 106448. https:\/\/doi.org\/10.1016\/J.CLINEURO.2020.106448","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"1","key":"8757_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1148\/RG.2019180081\/ASSET\/IMAGES\/LARGE\/RG.2019180081.FIG18B.JPEG","volume":"39","author":"LL Resende","year":"2019","unstructured":"Resende, L. L., de Paiva, A. R. B., Kok, F., da Leite, C., & Lucato, L. T. (2019). Adult leukodystrophies: A step-by-step diagnostic approach. Radiographics, 39(1), 153\u2013168. https:\/\/doi.org\/10.1148\/RG.2019180081\/ASSET\/IMAGES\/LARGE\/RG.2019180081.FIG18B.JPEG","journal-title":"Radiographics"},{"issue":"5","key":"8757_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., & Voelkerding, K. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405\u2013423. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genetics in Medicine"},{"issue":"11","key":"8757_CR16","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/JNR.23792","volume":"94","author":"JB Rosenberg","year":"2016","unstructured":"Rosenberg, J. B., Kaminsky, S. M., Aubourg, P., Crystal, R. G., & Sondhi, D. (2016). Gene therapy for metachromatic leukodystrophy. Journal of Neuroscience Research, 94(11), 1169\u20131179. https:\/\/doi.org\/10.1002\/JNR.23792","journal-title":"Journal of Neuroscience Research"},{"issue":"3","key":"8757_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/J.YMGME.2022.09.009","volume":"137","author":"V Santhanakumaran","year":"2022","unstructured":"Santhanakumaran, V., Groeschel, S., Harzer, K., Kehrer, C., Elg\u00fcn, S., Beck-W\u00f6dl, S., Hengel, H., Sch\u00f6ls, L., Haack, T. B., Kr\u00e4geloh-Mann, I., & Laugwitz, L. (2022). Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype?\u2014Chances and challenges. Molecular Genetics and Metabolism, 137(3), 273\u2013282. https:\/\/doi.org\/10.1016\/J.YMGME.2022.09.009","journal-title":"Molecular Genetics and Metabolism"},{"key":"8757_CR18","doi-asserted-by":"publisher","first-page":"576221","DOI":"10.3389\/FMED.2020.576221\/BIBTEX","volume":"7","author":"AA Shaimardanova","year":"2020","unstructured":"Shaimardanova, A. A., Chulpanova, D. S., Solovyeva, V. V., Mullagulova, A. I., Kitaeva, K. V., Allegrucci, C., & Rizvanov, A. A. (2020). Metachromatic leukodystrophy: Diagnosis, modeling, and treatment approaches. Frontiers in Medicine, 7, 576221. https:\/\/doi.org\/10.3389\/FMED.2020.576221\/BIBTEX","journal-title":"Frontiers in Medicine"},{"issue":"2","key":"8757_CR19","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0021-9258(19)85079-2","volume":"264","author":"C Stein","year":"1989","unstructured":"Stein, C., Gieselmann, V., Kreysing, J., Schmidt, B., Pohlmann, R., Waheed, A., Meyer, H. E., O'Brien, J. S., & von Figura, K. (1989). Cloning and expression of human arylsulfatase A. Journal of Biological Chemistry, 264(2), 1252\u20131259. https:\/\/doi.org\/10.1016\/S0021-9258(19)85079-2","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"8757_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/S00401-017-1739-1","volume":"134","author":"MS van der Knaap","year":"2017","unstructured":"van der Knaap, M. S., & Bugiani, M. (2017). Leukodystrophies: A proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathologica, 134(3), 351\u2013382. https:\/\/doi.org\/10.1007\/S00401-017-1739-1","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"8757_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/J.BEEM.2014.10.001","volume":"29","author":"DF Van Rappard","year":"2015","unstructured":"Van Rappard, D. F., Boelens, J. J., & Wolf, N. I. (2015). Metachromatic leukodystrophy: Disease spectrum and approaches for treatment. Best Practice & Research Clinical Endocrinology & Metabolism, 29(2), 261\u2013273. https:\/\/doi.org\/10.1016\/J.BEEM.2014.10.001","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"key":"8757_CR22","doi-asserted-by":"publisher","DOI":"10.1159\/000530375","author":"A Yari","year":"2023","unstructured":"Yari, A., Etesam, S., Zarifi, S., Parvizpour, S., & Miri-Moghaddam, E. (2023). Clinical manifestations associated with the domain-containing protein 2 gene mutation in an Iranian family with Spastic Paraplegia 54. Neurodegenerative Diseases. https:\/\/doi.org\/10.1159\/000530375","journal-title":"Neurodegenerative Diseases"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-023-08757-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12017-023-08757-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-023-08757-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T08:15:39Z","timestamp":1702541739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12017-023-08757-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8757"],"URL":"https:\/\/doi.org\/10.1007\/s12017-023-08757-y","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"type":"print","value":"1535-1084"},{"type":"electronic","value":"1559-1174"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"assertion":[{"value":"12 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Consent documents were obtained from adult participants to participate in the study. We obtained written informed consent from parents\/guardian\/next of kin for all participants aged under 18.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Written informed consent was obtained from the parent\/legal guardian of the patients for publication of the details of their medical case and any accompanying images presented in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Our investigation was carried out in accordance with the principles outlined in the Declaration of Helsinki, and we obtained permission from the Ethics Committee of Birjand Medical University (Ethics code: IR.BUMS.REC.1402.120).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}